et al.. The stellate vascular smooth muscle cell phenotype is induced by IL-1β via the secretion of PGE2 and subsequent cAMP-dependent protein kinase A activation.
Introduction
Atherosclerosis is the pathological process underlying most cardiovascular diseases, including acute coronary syndrome, peripheral artery disease and ischemic stroke. It is characterized by chronic inflammation of the arterial wall at sites of blood flow disturbance, leading to the formation of atherosclerotic plaques [1] . Atherosclerosis is promoted by hypercholesterolemia, which favors the infiltration of cholesterol-containing LDL into the intima of the vessels [2] , where it may be oxidized. Parietal monocytes, which differentiate into macrophages [3] and vascular smooth muscle cells (VSMCs), which have a macrophagelike phenotype, take up and destroy oxidized LDLs via their scavenger receptors. They then become foam cells, and acquire the ability to secrete several different cytokines, including tumor necrosis factor (TNF) and interleukin-1(IL-1) [4] . Other inflammatory cells, including natural killer cells and lymphocytes, also participate in chronic inflammation by releasing interferon  (IFN [5] . The secretion of these compounds contributes to the expansion of atherosclerotic lesions, notably by inducing medial VSMCs to undergo transdifferentiation, modifying their phenotype.
Actin polymerization is involved in the maintenance of the differentiated/contractile phenotype of VSMCs [6] [7] [8] . Disruption, defects of actin cytoskeleton protein smooth muscle 22 alpha (SM22 alpha) are associated with pro-inflammatory and chondrogenic changes to the VSMC phenotype, aggravating vascular inflammation and pathological remodeling [9, 10] .
The transdifferentiated VSMCs also acquire new cellular functions, including roles in migration and proliferation, and these functions are regulated by dynamic actin microfilament rearrangements that may result in changes to cell morphology [11] [12] [13] . Atherosclerosis development is thus associated with morphological changes to the intimal VSMCs, mostly resulting in the adoption of a stellate form due to the loss of focal adhesions and the disassembly of actin stress fibers. There are very few if any stellate cells in healthy human aortas, but the number of these cells steadily increases as fatty streaks gradually develop into advanced atherosclerotic plaques [14] . The role of VSMCs in atherogenesis may have been largely underestimated, because the markers used to identify these cells may not be appropriate [15] . Stellate VSMCs were first detected in human aortas, by electron microscopy, in 1986 [14] . This phenotype is well known in hepatic fibrosis [16] , but little is known about the role of stellate VSMCs in atherosclerosis and the potential mediators triggering the change in phenotype from contractile to stellate cells.
A C C E P T E D M A N U S C R I P T
ACCEPTED MANUSCRIPT 6 We show here that IL-1 was the only inflammatory mediator of those tested (IL-1, TNF and IFN, all of which are present in plaques) able to trigger the phenotypic transition from contractile to stellate cells in VSMCs. Early studies described an increase in cAMP concentration as the intracellular event leading VSMCs to adopt a stellate phenotype [17] [18] [19] [20] .
We therefore investigated the possible association of the IL-1-dependent transdifferentiation of VSMCs with the increase in intracellular [cAMP], using a FRET-based biosensor for cAMP ( T Epac VV , [21] ). This technique can be used to monitor real-time changes in intracellular [cAMP] in living cells. These experiments showed that the increase in intracellular [cAMP] in response to IL-1 stimulation was due to the secretion of a unique autocrine/paracine mediator, PGE 2 . By interacting with the EP4 receptor, PGE 2 stimulates cAMP production, in turn activating PKA and destabilizing the actin cytoskeleton and focal adhesions. receptor antagonists, L-798 106 (EP3R), SC51322 (EP1R) and ONO AE3208 (EP4R) were obtained from Tocris Bioscience, Bristol, United Kingdom.

Cell culture
Rats were euthanized by the i.p. injection of pentobarbital (300 mg/kg) and VSMCs were isolated as previously described [22] . The university ethics committee approved the experiments on rats and all animal procedures conformed to European Directive 2010/63/EU.
The VSMC response to IL-1 decreased rapidly with successive cell passages. We therefore performed all experiments on cells that had been subcultured only one to three times. We coated the wells of culture slides with collagen by incubation overnight. The wells were then seeded with cells at a density of 5000 cells/cm 2 , in DMEM containing 1g/l glucose, 4 mM Lglutamine, 10% fetal calf serum, 100 U/ml penicillin, 100 μg/ml streptomycin, and the plates were incubated for 96 h, at 37°C, under an atmosphere containing 5% CO 2 . The cells were starved by incubation in serum-free DMEM for 7 to 16 h before treatment. We prepared conditioned medium for FRET experiments, by starving the cells in serum-free Fluorobrite DMEM, to minimize background fluorescence.
Transfection with a small interfering RNA (siRNA)
VSMCs were grown to about 80% confluence, and were maintained for 2 h in antibiotic-free DMEM containing 1 g/l glucose, 4 mM L-glutamine, 10% FCS. Transfection was then performed by adding 0.25% Lipofectamine and 1 nM siRNA in 12.5 % Opti-MEM and incubating the cells for 24 h. The cells were then starved of serum and treated for 48 h.
The siRNAs used were a mixture of 30 different sequences called siPools purchased from Sitools Biotech GmbH (Planegg, Germany) and directed against rat PRKAR1 (NM_013181.1) and rat PRKAR1 (NM_001033679.1). 
Protein extraction and western blot analysis
Absolute quantification of mRNA copy number
Specific 250 to 1000 bp amplicons were generated from the RNA by RT-PCR and purified. Each amplicon was assayed and the number of copy was calculated according to its size in bp. Serial dilutions of known concentration were used in qPCR, to determine the fit coefficients of the relative standard curve. Absolute quantification was performed by interpolation of the PCR signal (Cq) into this standard curve with the Livak-Schmittgen equation [23] . The forward and reverse primers used were as follows: PKAC, for 10 s. Amplification was monitored online and the reaction was stopped at the end of the logarithmic phase. Melting curve analysis was carried out to check the specificity of PCR.
Controls and water blanks were included in each run, and all gave negative results. The qPCR analysis of serial dilutions of a mixture of cDNAs indicated that amplification efficiency was close to 100% for all the genes studied. The primer sequences used to amplify the cDNAs are shown in Table 1 .
Cytokine array
Conditioned medium from cultures of VSMCs treated with vehicle, IL-1β (5 ng/ml), TNFα (10 ng/ml) or IFNγ (10 ng/ml) for 72h was incubated with Proteome Profiler Rat Cytokine Array Panel A membranes (R&D Systems, Minneapolis, Minnesota, USA). These concentrations of cytokines were used throughout the study.
Immunocytochemistry
Collagen-coated coverslips were seeded with 5000 cells/cm 2 . The cells were grown to confluence and starved of serum, and they were then treated for 72 h with recombinant IL-1β, TNFα or IFNγ. Cells were fixed by incubation in 2% sucrose and 3% paraformaldehyde in PBS for 15 min at room temperature, and permeabilized by incubation with 0.2% Triton X-100 in PBS for 5 min. Non-specific sites were blocked by incubation with 5% FCS in PBS.
The cells were stained for actin and vinculin, by incubation for 2 h at 21°C with Alexa Fluor® 594-conjugated phalloidin and an FITC-conjugated monoclonal anti-vinculin antibody, in PBS containing 5% FCS. The cell nuclei were stained with 4',6'-diamidino-2-phenylindole (DAPI). The coverslips were mounted in Dako fluorescence mounting medium (Dako, Carpinteria, California, USA) and examined with a Nikon Diaphot 300 microscope (Nikon, Tokyo, Japan).
PGE 2 assay
PGE 2 secretion was evaluated with an enzyme immunoassay kit from Cayman
Chemical SPI-BIO, Massy, France.
Generation of T Epac VV cAMP biosensor-encoding adenovirus
T Epac VV , a FRET-based sensor for cAMP, consists of a cAMP-binding domain from the exchange protein directly activated by cAMP 1 (Epac1) sandwiched between the fluorescent donor (mTurquoise (cyan) and acceptor cpVenus-Venus (yellow) proteins [24] .
The cDNA encoding the T Epac VV biosensor was inserted between the BglII and XhoI restriction sites of the pShuttle plasmid (Agilent Biotechnology, Santa Clara, California, USA). The pShuttle-T Epac VV was linearized by digestion with PmeI and inserted into the pAdEasy-1 vector by homologous recombination. Recombinant viral vectors carrying the T Epac VV biosensor were produced in the HEK-293T cell line at UMR1089, Nantes, France.
Dynamics of cAMP production
VSMCs on collagen-coated glass coverslips were incubated with the T Epac VVencoding adenoviral vector (~100 particles per cell) for 24 h at 37°C, under an atmosphere containing 5% CO2. Coverslips were placed in a microscope chamber, continuously perfused (2 ml/min) with a buffer containing 125 mM NaCl, 2 mM CaCl2, 1 mM MgCl2, 1.25 mM NaH2PO4, 26 mM NaHCO3, 25 mM glucose and maintained at 32°C, saturated with 5% CO2-95% O 2 . TNFα, IFNγ or IL-1β was added during the perfusion.
Conditioned medium for the FRET experiments was obtained by treating VSMCs with IL-1, TNF or IFN for 72 h in FluoroBrite TM DMEM, a medium specially developed for the fluorescence imaging of live cells. We analyzed the dynamics of cAMP production after the addition of conditioned medium, in cells that had previously undergone transdifferentiation in response to exposure to IL-1β, TNFα or IFNγ for 48h and had then 
Time-lapse video microscopy
Sixteen hours before any treatment, cells were starved in serum-free DMEM. Changes in their morphology were then monitored by time-lapse video microscopy. Phase-contrast images (3 fields/well) were captured with a 20x objective, at 2.5-minute intervals, for 18 h.
Images were captured with an inverted microscope (DMI 6000B from Leica) equipped with a cell incubation chamber, a motorized stage, and a coolSNAP HQ2 CCD camera. All operations were controlled with Metamorph software (version 7.1).
Statistics
All data are presented as means ± SEM of at least three independent experiments.
Graphical representations were generated and the statistical significance of differences between groups were assessed with GraphPad Prism 5 (GraphPad Software, Inc., La Jolla, CA, USA). Pairwise comparisons of groups were carried out with two-tailed Mann-Whitney tests. For comparisons of multiple groups, we used Kruskal-Wallis tests followed by Dunn's multiple comparison tests. Differences were considered significant if P < 0.05.
Results
IL-1 increases intracellular [cAMP] via one or several autocrine/paracrine factors
Light microscopy (Figure 1A and Supplementary Videos 1-4) showed that IL-1 was the only cytokine of those tested capable of inducing the transition to a stellate form in VSMCs. In vitro, this phenomenon peaks about 12 hours after stimulation, tending to decrease thereafter, as shown by time-lapse imaging. It is followed by a second wave of transition to a stellate morphology beginning 48 h after the addition of IL-1 and intensifying until 72 h after the addition of this cytokine. The cAMP-dependent stellate morphology of VSMCs (induced by the -adrenergic receptor agonist isoproterenol) is characterized by a loss of focal adhesions and the disassembly of actin stress fibers [20] . We therefore also stained cells for actin and the focal adhesion marker vinculin. IL-1 disrupts focal adhesions and actin stress fibers, whereas neither TNF nor IFN modifies the cytoskeleton ( Figure   1B ). However, the treatment of VSMCs with IL-1, TNF or IFN for 48 h, followed by an analysis of mRNA levels for four major contractile markers showed that all these cytokines inhibited the expression of at least some of these markers, attesting to their efficacy. All three compounds decreased the levels of SM-MHC and calponin (Supplementary Figure S2) , but only IL- and TNF decreased SM22 (by ∼90 and 50%, respectively) and smoothelin (by ∼75 and 50%, respectively) mRNA levels to any great extent. Consistent with a cAMPdependent phenomenon, stellate cells were also obtained following an increase in intracellular data demonstrate that IL-1-induced VSMC transdifferentiation is different from that induced by the other cytokines tested. These data also suggest that this effect is at least partly dependent on the cAMP signaling pathway.
We investigated whether the IL-1-dependent transdifferentiation of VSMCs was associated with an increase in intracellular cAMP concentration, using the FRET biosensor T Epac VV [21] . We monitored changes in intracellular cAMP concentration by calculating the ratio of CFP fluorescence (F480nm) to YFP (F535nm) fluorescence. The baseline ratio at the start of the experiment was set to 1 and the maximum ratio change (Rmax) was systematically determined at the end of the experiment, by adding 10 µM forskolin and 200 µM isobutyl-L-methylxanthine (IBMX), a broad-spectrum phosphodiesterase inhibitor. Incubation with isoproterenol (used as a positive control) greatly increased the ratio to 90.0 ± 1.1% of the maximal ratio change (n=4, P < 0.001),,but none of the cytokines tested induced a detectable increase in intracellular [cAMP] over a similar timeframe (Figure 3) . Given the time taken for IL-1 to induce the transition to a stellate cell morphology, we hypothesized that any increase in cAMP concentration might be dependent on the production of autocrine/paracrine factors.
We used conditioned medium obtained from VSMCs treated with vehicle, IL-1, TNF or IFN for 72 h (referred to as vehicle-CM, IL-1-CM, TNF-CM and IFN-CM, respectively) to test this hypothesis. IL-1-CM immediately triggered a large increase in intracellular cAMP concentration (up to 34.5  3.8% of the maximum ratio, n = 4, P < 0.01), whereas the other conditioned media had no effect on cAMP (Figure 4 (left and middle panels) and Table 2 ). Consistent with this finding, the addition of IL-1-CM added to naive/contractile cells also rapidly (within less than 2 hours) triggered the transition to a stellate cell morphology (Figure 4B, right panels) , whereas treatment with IL-1 took at least 12 hours to achieve the same effect (Figure 1A) . The other two conditioned media (TNF-CM and IFN-CM) were inefficient regardless of the mode of monitoring used (dynamics of cAMP production or change in cell shape). Thus, stimulation with IL-1 leads to the release of one or several autocrine/paracrine factors, triggering an increase in the intracellular concentration of cAMP. These findings also demonstrate that cAMP production is a hallmark of IL-1dependent VSMC transdifferentiation.
The IL-1-dependent increase in intracellular [cAMP] involves PGE 2 secretion and PGE 2 receptor isoform 4 (EP4)
As a first step towards identifying the factors involved, we compared the secretion profiles of IL-1, TNF and IFN, in terms of their induction of the inflammatory cytokines/chemokines and enzymes involved in eicosanoid/PGE 2 synthesis at the mRNA and/or protein level. For most of the mRNAs studied, significant induction was observed with at least two of the cytokines tested, IL-1 and TNF, or IFN and TNF, indicating a very low likelihood of a role in stellate cell morphology for these mRNAs ( Table 3 and Figure 5 left panels A and B). However, the mRNAs encoding COX-2, CCL3, and VEGF-A were specifically and significantly induced by IL-1. It was also clear from our results that i)
TNF was the most potent cytokine for CCL5 mRNA synthesis; ii) IFN, which had no effect on the CCL5, CCL3, COX-2 and VEGF-A mRNAs, strongly induced synthesis of the CXCL10 mRNA encoding the chemo-attractant of T lymphocytes and monocytes. Using a cytokine array allowing the detection of 29 different inflammatory mediators and a PGE 2 assay, we were able to expand our results further, to show that, in addition to triggering the expression of CCL3 and VEGF, IL-1 also induced high levels of CXCL2, GM-CSF and IL6 expression, and PGE 2 secretion. It is also clear that i) IFN induces the production of small amounts of CXCL1, CX3CL1 and CCL5; ii) contractile vehicle-treated VSMCs have very low levels of secretory activity, because only CXCL1 and the tissue inhibitor matrix metalloproteinase-1 are detected in their culture medium.
Our data and those obtained for human VSMCs [25] suggested that PGE 2 was a potentially good candidate for relaying the increase in cAMP concentration in response to IL-1, particularly as PGE 2 triggered the transition to a stellate VSMC morphology within an hour, or even faster in some cases, depending on the number of cell subcultures (Supplementary Video 6). We therefore repeated the experiments carried out with IL-1-CM, successively blocking each of the three PGE 2 receptors expressed by VSMCs 1 . Each dose of antagonist was selected on the basis of published data, to yield maximal inhibition corresponding to 20 times the Ki value [26] [27] [28] . Neither the EP1 antagonist nor the EP3 antagonist (SC51322, L798,106, respectively) affected the increase in intracellular [cAMP] induced by IL-1-CM (Figure 6A and C). Conversely, when the EP4 antagonist ONO AE3208 was applied, intracellular
[cAMP] rapidly (within 2 minutes) returned to baseline levels. Consistently with the observation that the transition to a stellate shape was associated with an increase in intracellular [cAMP], ONO AE3 was the only compound capable of blocking this process efficiently in IL-1-CM-or PGE 2 -treated cells. In light of these findings and the observation that very similar results were obtained when IL-1-CM was replaced with PGE 2 (Figure 6B and D), we conclude that the autocrine/paracrine factor secreted upon IL-1 stimulation in VSMCs is unique and can be identified as PGE 2 .
The transition to a stellate morphology in VSMCs involves PKA
The regulation of cellular properties by cAMP is mediated principally by cyclic nucleotide-gated ion channels, the exchange proteins directly activated by cAMP (Epac-1 and greatly increased the number of stellate cells (Figure 7B) . By contrast, the same concentration of 6BNZ had almost no effect on contractile/naive cells (Figure 7A) . Epac stimulation of VSMCs transdifferentiating in response to IL-1 had no effect, regardless of the batch of 8-pCPT-O-Me-cAMP used (Figure 7B) . These results suggest that the IL-1induced/cAMP-dependent change in shape of VSMCs is mediated by PKA activation.
PKA is a holoenzyme with four subunits, two of which are catalytic, the other two being regulatory. The association of regulatory subunits R1α/R1β with any of the catalytic subunits (Cα, Cβ or C) defines PKA1, whereas an association of the regulatory subunits R2α/R2β with any of the catalytic subunits results in PKA2 and an inhibition of catalytic activity [29] .
These two enzymes also differ in terms of their location and affinity for cAMP. Rodents lack the catalytic subunit C. A comparison of mRNA levels for each of the subunits between naive/contractile and IL-1-treated VSMCs showed that the contractile/naïve VSMCs produced all four regulatory (R) subunits, the most abundant being R1 (65%), followed by R2 (22%), R2 (10%) and R1 (3 %); C and C accounted for 70% and 30% of catalytic subunits, respectively (Figure 7C, left panel) . IL-1 treatment induces a significant 40-fold increase in R1 gene expression 48 h after stimulation (Figure 7C, left Figure 7C left panel and data not shown) . Based on these data, we decided to silence R1α to confirm the involvement of PKA in this process. In many cell types and in vivo, the disruption of PKAR1 is associated with an increase in the catalytic activity of PKA [30] [31] [32] .
Consistent with a role for PKA in stellate cell morphology, knocking down R1α expression mimicked the effect of IL-1/PGE 2 on cell morphology, resulting in destabilization of the actin cytoskeleton and focal adhesions (as shown by immunostaining for F-actin and vinculin, respectively). Conversely, knocking down R1 expression had no impact (Figure 7D and   Supplementary Figure S4B ). Despite the increase in R1 mRNA levels observed on IL-1 treatment, the silencing of R1 in PGE 2 -treated cells did not prevent these cells from developing a stellate phenotype. The efficacy and specificity of R1 and  siRNAs were demonstrated by the determination of R1 and  mRNA levels after transfection (Supplementary Figure S4A) .
Discussion
The transdifferentiation of VSMCs in the inflammatory context of atherogenesis plays a key role in atherosclerosis, as highlighted by the recent study by Shankman et al., 2015 [15] .
Indeed, these authors showed that the contribution of VSMCs to atherosclerotic lesions had been greatly underestimated, due to their ability to develop the expression of macrophage, mesenchymal stem cell and/or myofibroblast markers in lesions. Given the known role of pancreatic stellate cells in acute episode of pancreatic injury [33] , it is possible that the stellate cells of the artery wall serve as extracellular matrix-producing cells or myofibroblasts, increasing plaque stability. However, chronic IL-1-treatment reduces the expression by VSMCs of profibrotic and/or proproliferative compounds, such as connective tissue growth factor and insulin growth factor-1 (Blirando et al. unpublished data) . It therefore appears more likely that the aortic stellate cells first produce large amounts of ECM proteins and then undergo a switch towards a phenotype with high levels of MMP activity. This remains to be demonstrated, but is consistent with the two waves of stellate cell development observed in vitro in response to short-and long-term stimulation with IL-1.
We show that, of the three key pro-atherogenic cytokines tested (IL-1, TNF and IFN), IL-1 was the most potent inducer (in terms of the numbers and amounts of secreted molecules) of the VSMC inflammatory response, triggering the release of substantial amounts of CCL3, GM-CSF, IL-6, VEGF-, CX3CL1, CXCL1, CXCL5 and PGE 2 . Consistent with published findings, IFN was the most efficient of the molecules tested for inducing CXCL10 expression in VSMCs [34] and TNF was a stronger inducer of CCL5 mRNA production than IL-1 [35] . Our findings also demonstrate that IL-1 was the only one of the molecules tested able to trigger the disruption of focal adhesions and actin stress fibers, leading to a cAMP-dependent transition to a stellate morphology, as observed in atherosclerotic lesions [14, 20] . Finally, using the FRET-based cAMP biosensor T Epac vv and a battery of pharmacological compounds, we were able to link this cAMP-dependent phenomenon to the autocrine/paracrine factor PGE 2 , which is released upon IL-1 stimulation and the activation of PKA by the EP4 prostaglandin receptor
The IL-1-induced increase in intracellular [cAMP] mediated by the release of the autocrine/paracrine factor PGE 2 is consistent with i) the time lag (12 h) observed between the start of IL-1-treatment and the development of a cAMP-dependent stellate cell morphology;
ii) our previous results showing that PGE 2 acts in synergy with IL-1 to enhance the phenotypic transition in smooth muscle cells [22] . It is also consistent with published data showing that the IL-1-mediated increase in cAMP concentration in VSMCs is due to the ability of IL-1 to trigger prostaglandin release [25, 36] .
Consistent with many other studies showing that EP4 activation leads to an increase in intracellular [cAMP] [37] , we showed, by successively blocking each of the EP receptors expressed in VSMCs, that the Gs-coupled EP receptor subtype 4 was involved in the increase in cAMP concentration and the transition to a stellate cell morphology. Following the addition of PGE 2 in conditions of EP receptor subtype 3 blockade, we observed a slight (but nonsignificant) decrease in cAMP production (Figure 6B) , leading the generation of fewer stellate VSMCs (Figure 6F , panels PGE2 vs. PGE2 +L-798, 106). This finding is consistent with our previous report showing that, in IL-1-treated cells, the PGE 2 -dependent increase in cAMP concentration results from activation of the EP4 and EP3 receptors [22] . Indeed, transdifferentiation is associated with a change in the regulation (negative to positive) of the G i -coupled receptor EP3, potentiating the cAMP produced by G s -coupled EP4 receptors. One reasons for the lack of significant results for the EP3 antagonist is that monitoring the dynamics of cAMP production by FRET requires the removal of IL-1 from the culture medium 24 h before the experiment. The VSMCs transdifferentiating in response to IL-1 may, therefore display partial reversion towards a quiescent phenotype, accounting for the small contribution of EP3 to the PGE 2 -induced increase in cAMP levels and changes in morphology.
Using the 6BNZ-cAMP (a PKA activator), a siRNA directed against the most abundant PKA regulatory subunit, R1α, and 8-pCPT-O-Me-cAMP (an Epac activator), we demonstrated the specific involvement of PKA in the cAMP-dependent transition towards a stellate cell phenomenon. However according to Hewer et al., (2011) , this transition towards a stellate phenotype in VSMCs results from a synergic activation of PKA and Epac not involving the Epac-dependent Rap1 protein [38] . Several studies have reported Rap1independent effects of Epac [39, 40] , but Epac activation generally leads to a Rap1-mediated GDP/GTP exchange [41] . As mentioned above, the disruption of PKAR1 in vivo is associated with an increase in the catalytic activity of PKA [30] [31] [32] , and this increase in catalytic activity (which is lethal in the embryo due to the failure to establish mesoderm-derived structures) is partially rescued by eliminating the PKA catalytic subunit  [42] , providing evidence for a causal relationship between the elimination of PKAR1 and the increase in PKA catalytic activity.
Embryonic fibroblasts from PKAR1 -/mouse embryos display similar changes in morphology to VSMCs in which R1 is silenced, with a decrease in activated Rac levels [32] .
Moreover, the transition of VSMCs to a stellate morphology induced by agents increasing cAMP levels, such as isoproterenol and forskolin, can be prevented by the expression of an activated form of Rac1. Conversely, the pharmacological inhibition of Rac1 or the expression of a dominant negative form of Rac1 is sufficient to induce the transition to a stellate phenotype [20] . Finally, PKAR1 disruption in Schwann cells is associated with a decrease in the formation of lamellopodia [31] , a process involving Rac1 activation [43] . This suggests a role for Rac1 in the PGE 2 /cAMP-dependent development of stellate morphology in VSMCs.
Furthermore, as PKA phosphorylates key actors involved in cytoskeletal regulation, such as the vasodilator-stimulated phosphoprotein (VASP) [18] , Ras homolog gene family member A (RhoA) [44] and LIM domain kinase 1 (LIMK1) [32] , these proteins may also be involved in the cAMP-dependent transition to a stellate phenotype. In any event, PKA enhances this process by phosphorylating globular actin (G-actin), thereby decreasing filamentous actin (Factin) formation [44] . Indeed, PKAR1 silencing induced a destabilization of filamentous actin and the disassembly of focal adhesions (Figure 7C) .
IL-1-dependent transdifferentiation is associated with an increase in PKAR1 gene expression. Nevertheless, the silencing of this subunit does not prevent VSMCs from undergoing the transition to a stellate phenotype following stimulation with PGE 2 (Figure   7B ). We therefore conclude that PKAR1 is not required for this process.
PKA containing PKAR1 subunits has been shown to be activated at cAMP concentrations lower, by a factor of three to seven, than those activating PKAR1 [45] . Therefore PKAdependent responses should be even more sensitive to any increase in intracellular cAMP concentration in VSMCs undergoing transdifferentiation in response to IL-1. Interestingly, in PKAR1-knockout mice, inflammation and nociceptive pain levels are low in a model of paw edema and pain behavior induced by formalin injection [46] . In addition, patients with systemic lupus erythematosus present a downregulation of PKAR1 expression and lower levels of IL-2 secretion by T lymphocytes, these deficits possibly being rescued by PKAR1 gene transfer [47] . The data presented here are consistent with a role for PKAR1 in the increase in cAMP concentration mediating VSMC inflammation and, possibly, PGE 2 secretion.
Conclusions and future prospects
VSMC transdifferentiation in response to exposure to pro-atherogenic stimuli, such as the cytokines IL-1, TNF and IFN, is a key event in the initiation and further development of atherosclerosis. We demonstrate here that IL-1 contributes to this transdifferentiation process not only by decreasing the expression of contractile markers, but also by disrupting Factin and focal adhesions through the release of PGE 2 and subsequent cAMP pathway activation. Given these and published findings, it will be of interest to investigate the effect on The antagonist concentrations were as follows, 280 nM for SC51322 (EP1), 6 nM for 
